Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
Market Place
ABOUT THIS PAGE
A Sodium Dihydrogen Phosphate Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Dihydrogen Phosphate Monohydrate, including repackagers and relabelers. The FDA regulates Sodium Dihydrogen Phosphate Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Dihydrogen Phosphate Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Dihydrogen Phosphate Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Dihydrogen Phosphate Monohydrate supplier is an individual or a company that provides Sodium Dihydrogen Phosphate Monohydrate active pharmaceutical ingredient (API) or Sodium Dihydrogen Phosphate Monohydrate finished formulations upon request. The Sodium Dihydrogen Phosphate Monohydrate suppliers may include Sodium Dihydrogen Phosphate Monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Dihydrogen Phosphate Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Dihydrogen Phosphate Monohydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Dihydrogen Phosphate Monohydrate active pharmaceutical ingredient (API) in detail. Different forms of Sodium Dihydrogen Phosphate Monohydrate DMFs exist exist since differing nations have different regulations, such as Sodium Dihydrogen Phosphate Monohydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Dihydrogen Phosphate Monohydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Dihydrogen Phosphate Monohydrate USDMF includes data on Sodium Dihydrogen Phosphate Monohydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Dihydrogen Phosphate Monohydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Dihydrogen Phosphate Monohydrate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Dihydrogen Phosphate Monohydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium Dihydrogen Phosphate Monohydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium Dihydrogen Phosphate Monohydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium Dihydrogen Phosphate Monohydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Dihydrogen Phosphate Monohydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium Dihydrogen Phosphate Monohydrate suppliers with NDC on PharmaCompass.
Sodium Dihydrogen Phosphate Monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Dihydrogen Phosphate Monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Dihydrogen Phosphate Monohydrate GMP manufacturer or Sodium Dihydrogen Phosphate Monohydrate GMP API supplier for your needs.
A Sodium Dihydrogen Phosphate Monohydrate CoA (Certificate of Analysis) is a formal document that attests to Sodium Dihydrogen Phosphate Monohydrate's compliance with Sodium Dihydrogen Phosphate Monohydrate specifications and serves as a tool for batch-level quality control.
Sodium Dihydrogen Phosphate Monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Dihydrogen Phosphate Monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Dihydrogen Phosphate Monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Dihydrogen Phosphate Monohydrate EP), Sodium Dihydrogen Phosphate Monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Dihydrogen Phosphate Monohydrate USP).
LOOKING FOR A SUPPLIER?
